Overview
CNS vasculitis
Autoimmune encephalitis
Juvenile arthritis
Systemic vasculitis
Autoimmune encephalitis
Juvenile arthritis
Systemic vasculitis
Current Appointments & Affiliations
Associate Professor of Pediatrics
·
2021 - Present
Pediatrics, Rheumatology,
Pediatrics
Chief, Division of Rheumatology
·
2020 - Present
Pediatrics, Rheumatology,
Pediatrics
Recent Publications
Retrospective Comparison of Patients Evaluated for Pediatric Autoimmune Encephalitis with Typical and Atypical Premorbid Neuropsychiatric Development.
Journal Article J Autism Dev Disord · June 2025 PURPOSE: Patients with neurodevelopmental disorders (NDD) (i.e. autism, developmental delay, early-onset psychiatric or seizure disorders) increasingly seek evaluation of new or exacerbated symptoms concerning for autoimmune encephalitis (AE). Clinical AE ... Full text Link to item CiteImplementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.
Journal Article Pediatr Rheumatol Online J · October 7, 2024 BACKGROUND: Chronic anterior uveitis (CAU) carries a significant risk for eye complications and vision loss. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) introduced consensus treatment plans (CTPs) to standardize treatment for CAU and ... Full text Link to item CiteDisease Course and Response to Immunotherapy in Children With Childhood Disintegrative Disorder: A Retrospective Case Series.
Journal Article J Child Neurol · January 2024 Childhood disintegrative disorder is a poorly understood neurobehavioral disorder of early childhood characterized by acute to subacute profound regression in previously developed language, social behavior, and adaptive functions. The etiology of childhood ... Full text Link to item CiteRecent Grants
Phase 2/3, Children and Adolescents With Aquaporin-4 antibody Positive (AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical TrialPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2024 - 2026Phase III EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2025 - 2026Arthritis Foundation Fellowship Training Grant 2019
FellowshipCo Investigator · Awarded by Arthritis Foundation · 2020 - 2024View All Grants
Education, Training & Certifications
University of Rochester ·
2001
M.D.